Investor Relations (IR) Questions: Prima Biomed Ltd PBMD
Click here to return to the biotech IRQ Index
Answers received: March 2013
1) When is the last time PBMD raised cash through an offering (diluted)?
In the second quarter 2011 Prima secured a total funding of A$41.25 million from an institutional placement on common stock and a Share Purchase Plan of common stock (similar to a rights issue) for the existing Shareholders.
2) How much cash (not cash equivalents) does PBMD have?
As reported in the Half Year Report Prima’s cash position (including term deposits) was app. A$ 28m at 31st of Dec 2012.
3) What and approximately when is the next known catalyst?
2Q CY 2013: Announce pilot trials of CVac in new cancer targets
3Q CY 2013: CAN-003 immune monitoring (ICS) final data
4Q CY 2013: CAN-003 progression-free survival final data and initial overall survival data
4) What is PBMD's quarterly cash burn?
Approximately A$ 5million per quarter. This may increase somewhat depending on recruitment of patients on the 800-patient phase 2/3 study.
5) Does PBMD have an existing line of credit and if so how much can they draw against it?
No, PBMD currently has no significant existing line of credit.
Jessica Brown
Prima BioMed USA, Inc.
1) When is the last time PBMD raised cash through an offering (diluted)?
In the second quarter 2011 Prima secured a total funding of A$41.25 million from an institutional placement on common stock and a Share Purchase Plan of common stock (similar to a rights issue) for the existing Shareholders.
2) How much cash (not cash equivalents) does PBMD have?
As reported in the Half Year Report Prima’s cash position (including term deposits) was app. A$ 28m at 31st of Dec 2012.
3) What and approximately when is the next known catalyst?
2Q CY 2013: Announce pilot trials of CVac in new cancer targets
3Q CY 2013: CAN-003 immune monitoring (ICS) final data
4Q CY 2013: CAN-003 progression-free survival final data and initial overall survival data
4) What is PBMD's quarterly cash burn?
Approximately A$ 5million per quarter. This may increase somewhat depending on recruitment of patients on the 800-patient phase 2/3 study.
5) Does PBMD have an existing line of credit and if so how much can they draw against it?
No, PBMD currently has no significant existing line of credit.
Jessica Brown
Prima BioMed USA, Inc.